Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Other Working Capital Changes (2022 - 2025)

Historic Other Working Capital Changes for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to $60037.0.

  • bioAffinity Technologies' Other Working Capital Changes fell 6777.44% to $60037.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $13299.0, marking a year-over-year decrease of 7819.55%. This contributed to the annual value of $105594.0 for FY2024, which is 14925.05% up from last year.
  • bioAffinity Technologies' Other Working Capital Changes amounted to $60037.0 in Q3 2025, which was down 6777.44% from -$23260.0 recorded in Q2 2025.
  • Over the past 5 years, bioAffinity Technologies' Other Working Capital Changes peaked at $530481.0 during Q3 2022, and registered a low of -$161445.0 during Q2 2023.
  • Its 4-year average for Other Working Capital Changes is $27618.4, with a median of -$11143.0 in 2022.
  • In the last 5 years, bioAffinity Technologies' Other Working Capital Changes plummeted by 84076.69% in 2023 and then soared by 12658.19% in 2024.
  • bioAffinity Technologies' Other Working Capital Changes (Quarter) stood at -$9424.0 in 2022, then plummeted by 554.01% to -$61634.0 in 2023, then soared by 72.37% to -$17032.0 in 2024, then skyrocketed by 452.5% to $60037.0 in 2025.
  • Its Other Working Capital Changes was $60037.0 in Q3 2025, compared to -$23260.0 in Q2 2025 and -$6446.0 in Q1 2025.